3660 related articles for article (PubMed ID: 7537173)
1. Activity of pp60c-src in 60 different cell lines derived from human tumors.
Budde RJ; Ke S; Levin VA
Cancer Biochem Biophys; 1994 Oct; 14(3):171-5. PubMed ID: 7537173
[TBL] [Abstract][Full Text] [Related]
2. Site-specific differences in pp60c-src activity in human colorectal metastases.
Termuhlen PM; Curley SA; Talamonti MS; Saboorian MH; Gallick GE
J Surg Res; 1993 Apr; 54(4):293-8. PubMed ID: 7687314
[TBL] [Abstract][Full Text] [Related]
3. Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells.
Kanner SB; Parsons SJ; Parsons JT; Gilmer TM
Oncogene; 1988 Apr; 2(4):327-35. PubMed ID: 2452399
[TBL] [Abstract][Full Text] [Related]
4. Analysis of pp60c-src in human colon carcinoma and normal human colon mucosal cells.
Bolen JB; Veillette A; Schwartz AM; Deseau V; Rosen N
Oncogene Res; 1987 Jul; 1(2):149-68. PubMed ID: 2453014
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of pp60c-src in low grade human bladder carcinoma.
Fanning P; Bulovas K; Saini KS; Libertino JA; Joyce AD; Summerhayes IC
Cancer Res; 1992 Mar; 52(6):1457-62. PubMed ID: 1371716
[TBL] [Abstract][Full Text] [Related]
6. pp60c-src in human melanocytes and melanoma cells exhibits elevated specific activity and reduced tyrosine 530 phosphorylation compared to human fibroblast pp60c-src.
O'Connor TJ; Neufeld E; Bechberger J; Fujita DJ
Cell Growth Differ; 1992 Jul; 3(7):435-42. PubMed ID: 1384653
[TBL] [Abstract][Full Text] [Related]
7. Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines.
Garcia R; Parikh NU; Saya H; Gallick GE
Oncogene; 1991 Nov; 6(11):1983-9. PubMed ID: 1719464
[TBL] [Abstract][Full Text] [Related]
8. c-Yes tyrosine kinase activity in human colon carcinoma.
Park J; Meisler AI; Cartwright CA
Oncogene; 1993 Oct; 8(10):2627-35. PubMed ID: 7690925
[TBL] [Abstract][Full Text] [Related]
9. Intestinal crypt cells contain higher levels of cytoskeletal-associated pp60c-src protein tyrosine kinase activity than do differentiated enterocytes.
Cartwright CA; Mamajiwalla S; Skolnick SA; Eckhart W; Burgess DR
Oncogene; 1993 Apr; 8(4):1033-9. PubMed ID: 7681158
[TBL] [Abstract][Full Text] [Related]
10. Analysis of pp60c-src tyrosine kinase activity and phosphotyrosyl phosphatase activity in human colon carcinoma and normal human colon mucosal cells.
DeSeau V; Rosen N; Bolen JB
J Cell Biochem; 1987 Oct; 35(2):113-28. PubMed ID: 2448318
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE
Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048
[TBL] [Abstract][Full Text] [Related]
12. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.
Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE
Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of the src proto-oncogene in hairy cell leukemia and a subgroup of B-cell lymphomas.
Lynch SA; Brugge JS; Fromowitz F; Glantz L; Wang P; Caruso R; Viola MV
Leukemia; 1993 Sep; 7(9):1416-22. PubMed ID: 7690441
[TBL] [Abstract][Full Text] [Related]
14. pp60c-src activation in hepatocellular carcinoma of humans and LEC rats.
Masaki T; Okada M; Shiratori Y; Rengifo W; Matsumoto K; Maeda S; Kato N; Kanai F; Komatsu Y; Nishioka M; Omata M
Hepatology; 1998 May; 27(5):1257-64. PubMed ID: 9581679
[TBL] [Abstract][Full Text] [Related]
15. Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen.
Stinson SF; Alley MC; Kopp WC; Fiebig HH; Mullendore LA; Pittman AF; Kenney S; Keller J; Boyd MR
Anticancer Res; 1992; 12(4):1035-53. PubMed ID: 1503399
[TBL] [Abstract][Full Text] [Related]
16. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
17. Novel phosphorylation at a mitotic site, serine 75, in human pp60c-src from unsynchronized human tumor cells having a spherical morphology.
Kato G; Maeda S
Biochem Biophys Res Commun; 1995 Nov; 216(2):619-29. PubMed ID: 7488156
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
[TBL] [Abstract][Full Text] [Related]
19. Coordinate alteration of pp60c-src abundance and c-src RNA expression in human neuroblastoma variants.
Veillette A; O'Shaughnessy J; Horak ID; Israel MA; Yee D; Rosen N; Fujita DJ; Kung HJ; Biedler JL; Bolen JB
Oncogene; 1989 Apr; 4(4):421-7. PubMed ID: 2470006
[TBL] [Abstract][Full Text] [Related]
20. Expression of N-myristoyltransferase inhibitor protein and its relationship to c-Src levels in human colon cancer cell lines.
Rajala RV; Dehm S; Bi X; Bonham K; Sharma RK
Biochem Biophys Res Commun; 2000 Jul; 273(3):1116-20. PubMed ID: 10891381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
